Study Evaluating PK/PD and Safety of Betrixaban in Pediatric Patients

    Not Recruiting
  • End date
    Apr 15, 2022
  • participants needed
  • sponsor
    Portola Pharmaceuticals
Updated on 25 January 2021
Study Trial Contact
Primary Contact
Vinnytsia Regional Children's Clinical Hospital, Department of Anesthesiology and Intensive Care (0.0 mi away) Contact
+14 other location


A Phase 1, Open-Label, Single-Dose, Non-Randomized Study to Evaluate Pharmacokinetics, Pharmacodynamics, and Safety of Betrixaban in Pediatric Patients

Condition VTE Prophylaxis
Treatment Betrixaban
Clinical Study IdentifierNCT03346083
SponsorPortola Pharmaceuticals
Last Modified on25 January 2021

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note